scholarly journals TWELVE YEARS OF PULMONARY TUBERCULOSIS TREATMENT IN THE WEST

1909 ◽  
Vol LII (25) ◽  
pp. 1973
Author(s):  
E. S. BULLOCK
Keyword(s):  
Pulmonary Tuberculosis ◽  
Tuberculosis Treatment ◽  
The West

scholarly journals Case Series of Three Patients with Rifampicin-Induced Thrombocytopenia

2020 ◽  
Author(s):  
Chandramouli M.T
Keyword(s):  
Pulmonary Tuberculosis ◽  
Adverse Reactions ◽  
Rare Complication ◽  
Case Series ◽  
Tuberculosis Treatment ◽  
Effective Drug ◽  
Antitubercular Drugs ◽  
Short Course ◽  
Life Threatening

AbstractLife-threatening adverse reactions of antitubercular drugs are uncommon; however, thrombocytopenia is one such rare complication encountered with rifampicin, isoniazid, ethambutol, and pyrazinamide. Rifampicin is the most effective drug and its use in the tuberculosis treatment led to the emergence of modern and effective short-course regimens. I am reporting case series of three patients with pulmonary tuberculosis presented with rifampicin-induced thrombocytopenia.

Symptoms to script: delays in tuberculosis treatment in the west of Ireland

2021 ◽  
Author(s):  
Conor Grant ◽  
Jack McHugh ◽  
Ciara Ryan ◽  
Margaret Scarry ◽  
Anthony O’Regan ◽  
...  
Keyword(s):  
Tuberculosis Treatment ◽  
The West ◽  
West Of Ireland

scholarly journals Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207404
Author(s):  
Gokul Raj Kathamuthu ◽  
Kadar Moideen ◽  
Vaithilingam V. Banurekha ◽  
Dina Nair ◽  
R. Sridhar ◽  
...  
Keyword(s):  
Growth Factors ◽  
Cell Growth ◽  
Pulmonary Tuberculosis ◽  
B Cell ◽  
Tuberculosis Treatment ◽  
Tuberculous Lymphadenitis ◽  
Circulating Levels

scholarly journals EXTRAPLEURAL PNEUMOLYSIS FOR CAVITARY PULMONARY TUBERCULOSIS TREATMENT

2020 ◽  
pp. 15-20
Author(s):  
P. G. Gadzhieva ◽  
D. B. Giller ◽  
A. A. Glotov ◽  
O. Sh. Kesaev ◽  
V. V. Koroev ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Multidrug Resistant ◽  
Pathological Process ◽  
Tuberculosis Treatment ◽  
Long Term Results ◽  
Filling Material ◽  
Different Types ◽  
Positive Effect ◽  
Observation Period

Objective. To increase efficiency of cavitary pulmonary tuberculosis treatment by developing modern indications and technology of extrapleural pneumolysis with filling material.Material and methods. We reviewed 25 patients with cavitary pulmonary tuberculosis and bacterial excretion who had undergone extrapleural pneumolysis with different types of filling material in 2004–2015. In 16 cases, we performed surgery in patients with one lung.Results. 56% of operated patients demonstrated extensively drug-resistant TB, 40% had multidrug-resistant TB. Cavities were closed and bacterial excretion ceased in 92% of patients at discharge. Long-term results with observation period from 1 to 12 years were analyzed in 24 patients, 17 (71%) of them had complete clinical efficacy.Conclusion. Extrapleural pneumolysis is a mini-invasive surgical treatment that can prove positive effect in patients with non-fibrotic changes in a cavity wall and pathological process in upper parts of the lungs. 

scholarly journals Korelasi Antara Lama Menjalani Pengobatan Tuberkulosis Paru Dengan Skor Depresi Pada Pasien Tuberkulosis Paru Yang Menjalani Pengobatan di Poliklinik Paru RSUD Dr. Pirngadi Medan

2021 ◽  
Vol 6 (2) ◽  
pp. 62-64
Author(s):  
Masdiwani Noviana Simanjuntak ◽  
Ade Pryta Simaremare ◽  
Rosminta Girsang
Keyword(s):  
Pulmonary Tuberculosis ◽  
Pearson Correlation ◽  
Depression Score ◽  
Tuberculosis Treatment ◽  
Term Therapy ◽  
Cross Sectional ◽  
Correlative Analysis ◽  
Pearson Correlation Test ◽  
Cross Sectional Design ◽  
Long Term Therapy

Background : Pulmonary tuberculosis is an infectious disease caused by mycobacterium tuberculosis. This bactery can be transmitted through airbone particles and droplets. The treatment is a long term therapy and can be a stressor which effect patient’s physical and psychologycal, that leads to depression. Objective : The objective of this study was to determine the correlation between pulmonary tuberculosis treatment duration and depression score.  Methods : This study was a correlative analysis with cross sectional design. The sample were 52 respondents whom currently endured the treatment of pulmonary tuberculosis in pulmonary unit in RSUD Pirngadi Medan, selected by consecutive sampling. Beck’s inventory depression II questionnaires were used to measure depression score. The data were analyzed with pearson correlation test.  Result : There was a low negative correlation between duration of pulmonary tuberculosis treatment and depression score (p = 0,027 ; r = -0,309) Conclusion  : The longer duration of pulmonary tuberculosis treatment, the lower the depression score. 

scholarly journals Cytokine polymorphisms, their influence and levels in Brazilian patients with pulmonary tuberculosis during anti-tuberculosis treatment.

2013 ◽  
Vol 4 ◽  
Author(s):  
Peresi Eliana ◽  
Oliveira Larissa ◽  
Da Silva Weber ◽  
Da Costa Erica ◽  
Araujo Junior Jo�o ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Tuberculosis Treatment

scholarly journals The Effect of Side Effects Tuberculosis Treatment in the Early Stage Towards Compliance with Tuberculosis Patients

2021 ◽  
Vol 5 (01) ◽  
pp. 29-32
Author(s):  
Joko Sapto Pramono ◽  
Nilam Noorma ◽  
Andi Lis Arming Gandini ◽  
Sopia Fitriani
Keyword(s):  
Side Effects ◽  
Pulmonary Tuberculosis ◽  
Health Workers ◽  
Early Stage ◽  
Treatment Compliance ◽  
Tuberculosis Treatment ◽  
Cross Sectional ◽  
Tuberculosis Patients ◽  
Early Stages ◽  
Significant Difference

Pulmonary tuberculosis treatment causes various side effects including nausea and vomiting, itching, vision problems, and anemia. Drug side effects in the early stages are one of the causes of non-adherence to complete treatment. The purpose of this study was to analyze the effect of the side effects Tuberculosis treatment in the early stages on treatment compliance for tuberculosis patients. This study used a cross sectional design. Samples were taken as many as 71 respondents, the instruments used were side effects of early-stage tuberculosis treatment and compliance with tuberculosis treatment in tuberculosis patients from the Morisky Medication Adherence Scale (MMAS). The results of the study found 97.7% adherent and 2.3% non-adherent, 39.5% mild side effects and 60.5% severe side effects. Chi-square test showed that no significant difference between the side effects of TB treatment in the early stages of tuberculosis treatment compliance in patients p = 0.669 at significant level of 95% (α = 0.05). There was no effect between the side effects of Tuberculosis treatment in the early stages of treatment compliance for Tuberculosis patients. It was recommended that health workers continue to monitor the side effects of tuberculosis treatment and provide motivation to carry out treatment completely. Keywords: side effects; early stage; treatment; pulmonary tuberculosis; compliance

Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand

2017 ◽  
Vol 42 (3) ◽  
pp. 337-344 ◽  
Author(s):  
P. Tanvejsilp ◽  
E. Pullenayegum ◽  
M. Loeb ◽  
J. Dushoff ◽  
F. Xie
Keyword(s):  
Pulmonary Tuberculosis ◽  
Pharmaceutical Care ◽  
Tuberculosis Treatment
Sign in / Sign up

Export Citation Format

Share Document